Caring for pregnant women and newborns with hepatitis B or C

American Family Physician

Volumn 82, Issue 10, 2010, Pages 1225-1229

  Vu Lam, Nguyet Cam ^a   Gotsch, Patricia B ^b   Langan, Robert C ^a  

^a St Luke's Family Medicine Residency   (United States)

^b Cornerstone Family Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; LAMIVUDINE; PLACEBO; TELBIVUDINE; TENOFOVIR DISOPROXIL; ANTIVIRUS AGENT;

ARTICLE; HEPATITIS B; HEPATITIS C; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; MATERNAL CARE; MATERNAL TREATMENT; NEWBORN CARE; NONHUMAN; NURSE PATIENT RELATIONSHIP; PREGNANT WOMAN; PRENATAL SCREENING; RISK FACTOR; UNSPECIFIED SIDE EFFECT; VERTICAL TRANSMISSION; VIRUS DETECTION; VIRUS TRANSMISSION; FEMALE; INCIDENCE; METHODOLOGY; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL DIAGNOSIS; PROGNOSIS; REVIEW; UNITED STATES; VACCINATION;

ANTIVIRAL AGENTS; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; INCIDENCE; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL DIAGNOSIS; PROGNOSIS; RISK FACTORS; UNITED STATES; VACCINATION;

EID: 79952116375     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Mast EE, Margolis HS, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents [published corrections appear in MMWR Morb Mortal Wkly Rep. 2006;55(6):158-159 and MMWR Morb Mortal Wkly Rep. 2007;56(48):1267]. MMWR Recomm Rep. 2005;54(RR-16):1-31.
2. Centers for Disease Control and Prevention (CDC). Implementation of newborn hepatitis B vaccination-worldwide, 2006. MMWR Morb Mortal Wkly Rep. 2008;57(46):1249-1252.
3. Airoldi J, Berghella V. Hepatitis C and pregnancy. Obstet Gynecol Surv. 2006;61(10):666-672.
4. Yeung LT, King SM, Roberts EA. Mother-to-infant transmission of hepatitis C virus. Hepatology. 2001;34(2):223-229.
5. U.S. Preventive Services Task Force. Screening for hepatitis B infection. February 2004. http://www.uspreventiveservicestaskforce.org/uspstf/uspshepb.htm. Accessed September 5, 2010.
6. American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 86: viral hepatitis in pregnancy. Obstet Gynecol. 2007;110(4):941-956.
7. American Academy of Family Physicians. Clinical preventive services. June 2010. http://www.aafp.org/online/en/home/clinical/exam.html. Accessed September 5, 2010.
8. Pickering LK. Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, Ill.: American Academy of Pediatrics; 2006.
9. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50(3):661-662.
10. U.S. Preventive Services Task Force. Screening for hepatitis B virus infection in pregnancy: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2009;150(12):869-873, W154.
11. Weinbaum CM, Williams I, Mast EE, et al.; Centers for Disease Control and Prevention (CDC). Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep. 2008;57(RR-8):1-20.
12. Centers for Disease Control and Prevention. Prenatal care provider policies and procedures to prevent perinatal hepatitis B virus transmission. http://www.cdc.gov/hepatitis/HBV/PDFs/PrenatalCareProviderPoliciesAndProcedures.pdf. Accessed September 5, 2010.
13. Tyzeka (telbivudine) tablets [prescribing information]. East Hanover, N.J.: Novartis Pharmaceuticals Corporation; 2009. http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022011s001lbl.pdf. Accessed September 5, 2010.
14. Viread (tenofovir disoproxil fumarate) tablets [prescribing information]. Foster City, Ca.: Gilead Sciences, Inc.; 2008. http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021356s026lbl.pdf. Accessed September 5, 2010.
15. Xu WM, Cui YT, Wang L, et al. Efficacy and safety of lamivudine in late pregnancy for the prevention of mother-child transmission of hepatitis B; a multicentre, randomised, double-blind, placebo-controlled study. Hepatology. 2004;40(4 suppl 1):272A-273A.
16. Xu DZ, Yan YP, Choi BC, et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol. 2002;67(1):20-26.
17. Wang JS, Zhu QR, Wang XH. Breastfeeding does not pose any additional risk of immunoprophylaxis failure on infants of HBV carrier mothers. Int J Clin Pract. 2003;57(2):100-102.
18. Pickering LK. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, Ill.: American Academy of Pediatrics; 2009: 349-351.
19. Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers. Cochrane Database Syst Rev. 2006;(2):CD004790.
20. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Recomm Rep. 1998;47(RR-19):1-39.
21. Workowski KA, Berman SM; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006 [published correction appears in MMWR Recomm Rep. 2006;55(36):997]. MMWR Recomm Rep. 2006;55(RR-11):1-94.
22. Ghany MG, Strader DB, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009;49(4):1335-1374.
23. Paternoster DM, Santarossa C, Grella P, et al. Viral load in HCV RNA-positive pregnant women. Am J Gastroenterol. 2001;96(9):2751-2754.
24. Kilham L, Ferm VH. Congenital anomalies induced in hamster embryos with ribavirin. Science. 1977;195(4276):413-414.
25. Mcintyre PG, Tosh K, McGuire W. Caesarean section versus vaginal delivery for preventing mother to infant hepatitis C virus transmission. Cochrane Database Syst Rev. 2006;(4):CD005546.
26. Committee on Health Care for Underserved Women, American College of Obstetricians and Gynecologists. ACOG committee opinion no. 361: breastfeeding: maternal and infant aspects. Obstet Gynecol. 2007;109(2 pt 1):479-480.
27. England K, Pembrey L, Tovo PA, Newell ML; European Paediatric HCV Network. Excluding hepatitis C virus (HCV) infection by serology in young infants of HCV-infected mothers [published correction appears in Acta Paediatr. 2005;94(6):814]. Acta Paediatr. 2005;94(4):444-450.
28. National Institutes of Health. Management of hepatitis C: 2002. National Institutes of Health consensus conference statement. June 10-12, 2002. http://consensus.nih.gov/2002/2002HepatitisC2002116PDF.pdf. Accessed September 5, 2010.